BC200 is an unfavorable prognostic factor in these and other cancer contexts, such as bladder cancer, where exosomal transfer of BC200 RNA reportedly enhances VEGF-C/VEGFR3 signaling and lymphatic metastasis (Zheng et al., 2021). This evidence concerns the gene BCYRN1 and cancer.